Contact
searchSearch
HMP Global

General Neurology Topic Center

Recent News and Updates

broken DNA strand
News
Gene Therapy May Offer an Effective Alternative to Cochlear Implantation in Patients With Congenital Deafness
07/25/2025
Maria Mantas
Patients with congenital deafness who received OTOF gene therapy saw stable hearing recovery and faster improvements in auditory and speech performance than those who had received cochlear implantation.
Patients with congenital deafness who received OTOF gene therapy saw stable hearing recovery and faster improvements in auditory and speech performance than those who had received cochlear implantation.
Patients with congenital...
07/25/2025
Neurology
Doctors examine brain scans
News
GLP-1 RAs May Offer Novel Approach for Idiopathic Intracranial Hypertension Management
07/21/2025
Jolynn Tumolo
Patients with idiopathic intracranial hypertension (IIH) treated with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) had lower medication use, fewer symptoms, and a reduced need for procedural interventions.
Patients with idiopathic intracranial hypertension (IIH) treated with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) had lower medication use, fewer symptoms, and a reduced need for procedural interventions.
Patients with idiopathic...
07/21/2025
Neurology
Alzheimer Disease & Cognitive Disorders Symposium
Conference Coverage
Alzheimer's Disease and Cognitive Disorders Symposium: Agenda Highlights
07/17/2025
Marwan Sabbagh, MD
Learn more about the Alzheimer's Disease and Cognitive Disorder Symposium with this video from Co-Chair Marwan Sabbagh, MD, FAAN, FANA.
Learn more about the Alzheimer's Disease and Cognitive Disorder Symposium with this video from Co-Chair Marwan Sabbagh, MD, FAAN, FANA.
Learn more about the Alzheimer's...
07/17/2025
Neurology
ADCD symposium
Conference Coverage
Introducing the Alzheimer's Disease and Cognitive Disorders Symposium
07/07/2025
Marc E. Agronin, MD; W. Clay Jackson, MD, DipTh
Meeting co-chairs Marc Agronin and W. Clay Jackson introduce this new symposium and share why healthcare providers should attend.
Meeting co-chairs Marc Agronin and W. Clay Jackson introduce this new symposium and share why healthcare providers should attend.
Meeting co-chairs Marc Agronin...
07/07/2025
Neurology
An orange prescription container with generic pills spilling out in front of it
News
Association Found Between Psychiatric Medication Use and Risk of ALS
06/18/2025
Brionna Mendoza
A case-control study has identified a potential link between use of certain psychiatric medications and the risk and progression of amyotrophic lateral sclerosis (ALS). Findings were published in JAMA Network Open.
A case-control study has identified a potential link between use of certain psychiatric medications and the risk and progression of amyotrophic lateral sclerosis (ALS). Findings were published in JAMA Network Open.
A case-control study has...
06/18/2025
Neurology
diagnosing brain injury
News
Intensive Blood Pressure Reduction After ICH Not Linked to Ischemic Lesions
04/28/2025
Meagan Thistle
Intensive systolic blood pressure (SBP) lowering after intracerebral hemorrhage (ICH) does not increase the risk of ischemic brain injury, according to a new randomized clinical trial.
Intensive systolic blood pressure (SBP) lowering after intracerebral hemorrhage (ICH) does not increase the risk of ischemic brain injury, according to a new randomized clinical trial.
Intensive systolic blood...
04/28/2025
Neurology
A new mom sits on the couch holding her infant, and her forehead
News
Gestational Hypertension, Preeclampsia, and Eclampsia Associated With Greater Incidence of Future Neurological Disorders
02/13/2025
Brionna Mendoza
A recent Swedish cohort study of primiparous women found that those who experienced gestational hypertension, preeclampsia, and eclampsia were at increased risk for new-onset neurological disorders months or years after giving birth.
A recent Swedish cohort study of primiparous women found that those who experienced gestational hypertension, preeclampsia, and eclampsia were at increased risk for new-onset neurological disorders months or years after giving birth.
A recent Swedish cohort study of...
02/13/2025
Neurology
A person holds a cannabis joint in their hands
News
Cannabis Use Linked With Diminished Brain Activation in Young Adults
02/11/2025
Jolynn Tumolo
A lifetime history of heavy cannabis use in young adults was associated with lower brain activation during a working memory task, according to a study in JAMA Network Open
A lifetime history of heavy cannabis use in young adults was associated with lower brain activation during a working memory task, according to a study in JAMA Network Open
A lifetime history of heavy...
02/11/2025
Neurology
Intensive Blood Pressure Control Lowers Cognitive Impairment Risk Years Later
News
Intensive Blood Pressure Control Lowers Cognitive Impairment Risk Years Later
02/05/2025
Jolynn Tumolo
Just over 3 years of intensive treatment to reduce systolic blood pressure in adults with hypertension and high cardiovascular risk resulted in a lower rate of cognitive impairment 7 years later, according to a study published in Neurology.
Just over 3 years of intensive treatment to reduce systolic blood pressure in adults with hypertension and high cardiovascular risk resulted in a lower rate of cognitive impairment 7 years later, according to a study published in Neurology.
Just over 3 years of intensive...
02/05/2025
Neurology
Researchers Report Best Times for Biomarker Assessment After NMOSD Attacks
News
Researchers Report Best Times for Biomarker Assessment After NMOSD Attacks
02/03/2025
Jolynn Tumolo
The optimal times to assess sGFAP and sNfL when evaluating attacks in patients with neuromyelitis optica spectrum disorder (NMOSD) were within 1 week for sGFAP and 1 to 8 weeks for sNfL, according to study results published in JAMA Neurology.
The optimal times to assess sGFAP and sNfL when evaluating attacks in patients with neuromyelitis optica spectrum disorder (NMOSD) were within 1 week for sGFAP and 1 to 8 weeks for sNfL, according to study results published in JAMA Neurology.
The optimal times to assess...
02/03/2025
Neurology
Before what gestational age can brain death not be determined?
Quiz
Before what gestational age can brain death not be determined?
01/13/2025
Test your guideline knowledge!
Test your guideline knowledge!
Test your guideline knowledge!
01/13/2025
Neurology

Quizzes

Before what gestational age can brain death not be determined?
Quiz
Before what gestational age can brain death not be determined?
01/13/2025
Test your guideline knowledge!
Test your guideline knowledge!
Test your guideline knowledge!
01/13/2025
Neurology
quiz
Quiz
Age-Response Connection in Multilocus Sequential rTMS Therapy for Tinnitus With Comorbid Mental Health Conditions
03/18/2024
According to a recent study, which patient group is more likely to initially show less improvement in tinnitus symptoms when undergoing multilocus sequential rTMS therapy?
According to a recent study, which patient group is more likely to initially show less improvement in tinnitus symptoms when undergoing multilocus sequential rTMS therapy?
According to a recent study,...
03/18/2024
Psych Congress Network
Four people ponder with question marks over their heads
Quiz
How does serious mental illness affect risk of death after COVID-19 infection?
11/29/2023
Test your clinical knowledge with this quiz!
Test your clinical knowledge with this quiz!
Test your clinical knowledge...
11/29/2023
Neurology
Pencils spell out quiz.
Quiz
What kind of brain inflammation does COVID-19 infection cause?
04/12/2023
Test your neurology knowledge with this quiz!
Test your neurology knowledge with this quiz!
Test your neurology knowledge...
04/12/2023
Neurology
Some heart-healthy foods, including fruits and vegetables.
Quiz
How much can a heart-healthy lifestyle reduce stroke risk in those with high genetic risk?
08/12/2022
Take the quiz to test your neurology knowledge!
Take the quiz to test your neurology knowledge!
Take the quiz to test your...
08/12/2022
Neurology
People raising hands to answer question.
Quiz
Which conditions did access to medical marijuana improve?
07/15/2022
Take the quiz to test your knowledge!
Take the quiz to test your knowledge!
Take the quiz to test your...
07/15/2022
Neurology
a printed test, pencil, and clock on a desk
Quiz
Addressing Non-Response in Migraine Treatment
03/09/2026
Maria Mantas
Test your knowledge with this quick quiz!
Test your knowledge with this quick quiz!
Test your knowledge with this...
03/09/2026
Neurology
Pencils spell out quiz on their erasers
Expert Insights Quiz
Outcomes Following OSA Diagnosis
01/13/2026
Brionna Mendoza
Test your knowledge of recent research with this quiz!
Test your knowledge of recent research with this quiz!
Test your knowledge of recent...
01/13/2026
Neurology
test
Quiz
Heart Attacks and Late-Onset Epilepsy Risk
12/29/2025
Maria Mantas
What was the association between myocardial infarction and late-onset epilepsy risk in older adults?
What was the association between myocardial infarction and late-onset epilepsy risk in older adults?
What was the association between...
12/29/2025
Neurology
Pop quiz written on a blackboard with white chalk
Quiz
Delandistrogene Moxeparvovec for Duchenne Muscular Dystrophy
10/22/2025
Brionna Mendoza
Test your knowledge with this quiz!
Test your knowledge with this quiz!
Test your knowledge with this...
10/22/2025
Neurology
Pop quiz written on a blackboard with white chalk
Expert Insights Quiz
Mimics in Excessive Daytime Sleepiness
09/10/2025
Nishi Bhopal, MD
Test your knowledge with this quiz!
Test your knowledge with this quiz!
Test your knowledge with this...
09/10/2025
Neurology
quiz
Quiz
Early DOAC Initiation in AF-Related Ischemic Stroke
08/27/2025
Maria Mantas
Do you remember the details of this meta-analysis?
Do you remember the details of this meta-analysis?
Do you remember the details of...
08/27/2025
Neurology
Pop quiz written on a blackboard with white chalk
Quiz
Vyalev Contraindications
07/29/2025
Brionna Mendoza
Test your knowledge with this quick quiz!
Test your knowledge with this quick quiz!
Test your knowledge with this...
07/29/2025
Neurology
four people ponder a question with question marks over their head
Quiz
Dopaminergic Therapy in Early Parkinson Disease
07/10/2025
Test your guideline knowledge with this quick quiz!
Test your guideline knowledge with this quick quiz!
Test your guideline knowledge...
07/10/2025
Neurology
Three illustrated faces, one sad, one neutral, one happy, with a human hand picking up the happy face
Quiz
Head Positioning Before Thrombectomy
06/25/2025
Test your knowledge with this quick quiz!
Test your knowledge with this quick quiz!
Test your knowledge with this...
06/25/2025
Neurology
Pop quiz written on a blackboard with white chalk
Quiz
Epidural Steroids for Spinal Stenosis
06/12/2025
Brionna Mendoza
Test your clinical guideline knowledge with this quick quiz!
Test your clinical guideline knowledge with this quick quiz!
Test your clinical guideline...
06/12/2025
Neurology

News

broken DNA strand
News
Gene Therapy May Offer an Effective Alternative to Cochlear Implantation in Patients With Congenital Deafness
07/25/2025
Maria Mantas
Patients with congenital deafness who received OTOF gene therapy saw stable hearing recovery and faster improvements in auditory and speech performance than those who had received cochlear implantation.
Patients with congenital deafness who received OTOF gene therapy saw stable hearing recovery and faster improvements in auditory and speech performance than those who had received cochlear implantation.
Patients with congenital...
07/25/2025
Neurology
Doctors examine brain scans
News
GLP-1 RAs May Offer Novel Approach for Idiopathic Intracranial Hypertension Management
07/21/2025
Jolynn Tumolo
Patients with idiopathic intracranial hypertension (IIH) treated with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) had lower medication use, fewer symptoms, and a reduced need for procedural interventions.
Patients with idiopathic intracranial hypertension (IIH) treated with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) had lower medication use, fewer symptoms, and a reduced need for procedural interventions.
Patients with idiopathic...
07/21/2025
Neurology
An orange prescription container with generic pills spilling out in front of it
News
Association Found Between Psychiatric Medication Use and Risk of ALS
06/18/2025
Brionna Mendoza
A case-control study has identified a potential link between use of certain psychiatric medications and the risk and progression of amyotrophic lateral sclerosis (ALS). Findings were published in JAMA Network Open.
A case-control study has identified a potential link between use of certain psychiatric medications and the risk and progression of amyotrophic lateral sclerosis (ALS). Findings were published in JAMA Network Open.
A case-control study has...
06/18/2025
Neurology
diagnosing brain injury
News
Intensive Blood Pressure Reduction After ICH Not Linked to Ischemic Lesions
04/28/2025
Meagan Thistle
Intensive systolic blood pressure (SBP) lowering after intracerebral hemorrhage (ICH) does not increase the risk of ischemic brain injury, according to a new randomized clinical trial.
Intensive systolic blood pressure (SBP) lowering after intracerebral hemorrhage (ICH) does not increase the risk of ischemic brain injury, according to a new randomized clinical trial.
Intensive systolic blood...
04/28/2025
Neurology
A new mom sits on the couch holding her infant, and her forehead
News
Gestational Hypertension, Preeclampsia, and Eclampsia Associated With Greater Incidence of Future Neurological Disorders
02/13/2025
Brionna Mendoza
A recent Swedish cohort study of primiparous women found that those who experienced gestational hypertension, preeclampsia, and eclampsia were at increased risk for new-onset neurological disorders months or years after giving birth.
A recent Swedish cohort study of primiparous women found that those who experienced gestational hypertension, preeclampsia, and eclampsia were at increased risk for new-onset neurological disorders months or years after giving birth.
A recent Swedish cohort study of...
02/13/2025
Neurology
A person holds a cannabis joint in their hands
News
Cannabis Use Linked With Diminished Brain Activation in Young Adults
02/11/2025
Jolynn Tumolo
A lifetime history of heavy cannabis use in young adults was associated with lower brain activation during a working memory task, according to a study in JAMA Network Open
A lifetime history of heavy cannabis use in young adults was associated with lower brain activation during a working memory task, according to a study in JAMA Network Open
A lifetime history of heavy...
02/11/2025
Neurology
Intensive Blood Pressure Control Lowers Cognitive Impairment Risk Years Later
News
Intensive Blood Pressure Control Lowers Cognitive Impairment Risk Years Later
02/05/2025
Jolynn Tumolo
Just over 3 years of intensive treatment to reduce systolic blood pressure in adults with hypertension and high cardiovascular risk resulted in a lower rate of cognitive impairment 7 years later, according to a study published in Neurology.
Just over 3 years of intensive treatment to reduce systolic blood pressure in adults with hypertension and high cardiovascular risk resulted in a lower rate of cognitive impairment 7 years later, according to a study published in Neurology.
Just over 3 years of intensive...
02/05/2025
Neurology
Researchers Report Best Times for Biomarker Assessment After NMOSD Attacks
News
Researchers Report Best Times for Biomarker Assessment After NMOSD Attacks
02/03/2025
Jolynn Tumolo
The optimal times to assess sGFAP and sNfL when evaluating attacks in patients with neuromyelitis optica spectrum disorder (NMOSD) were within 1 week for sGFAP and 1 to 8 weeks for sNfL, according to study results published in JAMA Neurology.
The optimal times to assess sGFAP and sNfL when evaluating attacks in patients with neuromyelitis optica spectrum disorder (NMOSD) were within 1 week for sGFAP and 1 to 8 weeks for sNfL, according to study results published in JAMA Neurology.
The optimal times to assess...
02/03/2025
Neurology
Brain health
News
Mood Changes May Be a Prodromal Symptom in Sporadic Creutzfeldt-Jakob Disease
01/09/2025
Brionna Mendoza
Mood changes may precede symptom onset in sporadic Creutzfeldt-Jakob disease (sCJD) as early as 3 years, according to the findings from a retrospective case-control study published in JAMA Neurology.
Mood changes may precede symptom onset in sporadic Creutzfeldt-Jakob disease (sCJD) as early as 3 years, according to the findings from a retrospective case-control study published in JAMA Neurology.
Mood changes may precede symptom...
01/09/2025
Neurology
Investigational Drug Improves Motor Function in Patients With SMA
News
Investigational Drug Improves Motor Function in Patients With SMA
10/16/2024
Jolynn Tumolo
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational...
10/16/2024
Neurology
a woman holds another person's hand for support
News
Suicidality at Epilepsy Diagnosis Predicts Future Drug Resistance Risk
03/16/2026
Maria Mantas
A prospective cohort study found that suicidality at the time of focal epilepsy diagnosis was linked to a more than twofold increased risk of future antiseizure medication (ASM) treatment resistance.
A prospective cohort study found that suicidality at the time of focal epilepsy diagnosis was linked to a more than twofold increased risk of future antiseizure medication (ASM) treatment resistance.
A prospective cohort study found...
03/16/2026
Neurology
A woman lies on the couch holding an ice pack to her head
News
Migraine Nearly Doubles Depression and Anxiety Risk in Cohort Study
03/10/2026
Brionna Mendoza
Patients with migraine are at 2 times the risk for depression or anxiety compared to those without migraine, according to a large nationwide Swedish cohort study published in The Journal of Headache and Pain.
Patients with migraine are at 2 times the risk for depression or anxiety compared to those without migraine, according to a large nationwide Swedish cohort study published in The Journal of Headache and Pain.
Patients with migraine are at 2...
03/10/2026
Psych Congress Network
A nurse and a doctor review information on a computer in a lab clinical study research trial
News
Fenebrutinib for Multiple Sclerosis Returns Significant Phase III Results
03/04/2026
Brionna Mendoza
The pivotal Phase III FENhance 1 trial of fenebrutinib met its primary endpoint in relapsing multiple sclerosis (RMS), demonstrating statistically significant and clinically meaningful reductions in relapse activity.
The pivotal Phase III FENhance 1 trial of fenebrutinib met its primary endpoint in relapsing multiple sclerosis (RMS), demonstrating statistically significant and clinically meaningful reductions in relapse activity.
The pivotal Phase III FENhance 1...
03/04/2026
Neurology
a bowl of fruits and vegetables indicates brain health
News
DASH Diet Linked to Lower Subjective Cognitive Decline Risk
03/02/2026
Maria Mantas
In a prospective cohort of 159,347 US adults, higher adherence to 6 healthy dietary patterns was associated with lower risk of subjective cognitive decline (SCD).
In a prospective cohort of 159,347 US adults, higher adherence to 6 healthy dietary patterns was associated with lower risk of subjective cognitive decline (SCD).
In a prospective cohort of...
03/02/2026
Neurology
a colorful illustration of the brain
News
Five-Year Ublituximab Efficacy Sustained in Relapsing MS Trial
02/23/2026
Maria Mantas
Ublituximab provided sustained reductions in disease activity and disability progression over 5 years in adults with relapsing multiple sclerosis (RMS), according to open-label extension study findings.
Ublituximab provided sustained reductions in disease activity and disability progression over 5 years in adults with relapsing multiple sclerosis (RMS), according to open-label extension study findings.
Ublituximab provided sustained...
02/23/2026
Neurology
a row of pill bottles on a shelf
News
Cenobamate Shows Superior Effectiveness in Drug-Resistant Focal Epilepsy
02/17/2026
Maria Mantas
A large, pooled analysis found that cenobamate outperformed brivaracetam, lacosamide, and perampanel as adjunctive therapy in adults with drug-resistant focal epilepsy.
A large, pooled analysis found that cenobamate outperformed brivaracetam, lacosamide, and perampanel as adjunctive therapy in adults with drug-resistant focal epilepsy.
A large, pooled analysis found...
02/17/2026
Neurology
Two doctors review research data on a computer in a lab
News
Intravenous Tenecteplase Improves Functional Outcomes in Extended-Window Non-LVO Stroke
02/12/2026
Brionna Mendoza
The OPTION randomized clinical trial investigated whether intravenous tenecteplase administered in an extended time window after ischemic stroke onset benefits patients with non-large vessel occlusion (non-LVO) and evidence of salvageable...
The OPTION randomized clinical trial investigated whether intravenous tenecteplase administered in an extended time window after ischemic stroke onset benefits patients with non-large vessel occlusion (non-LVO) and evidence of salvageable...
The OPTION randomized clinical...
02/12/2026
Neurology
a doctor reviews brain scans
News
Phase 2 Odatroltide Trials Show Promise for Acute Ischemic Stroke Patients
02/09/2026
Maria Mantas
Data from 2 phase 2 trials suggest that LT3001 (odatroltide), a novel dual-mechanism stroke therapy, may offer functional improvement in patients with acute ischemic stroke who cannot receive standard reperfusion treatments.
Data from 2 phase 2 trials suggest that LT3001 (odatroltide), a novel dual-mechanism stroke therapy, may offer functional improvement in patients with acute ischemic stroke who cannot receive standard reperfusion treatments.
Data from 2 phase 2 trials...
02/09/2026
Neurology
An orange prescription container with generic pills spilling out in front of it
News
Antidepressant Use Not Linked to Worse Traumatic Brain Injury Outcomes
02/03/2026
Brionna Mendoza
A large nationwide cohort study found no evidence that preinjury antidepressant use increases short-term mortality, need for emergency brain surgery, or length of hospitalization following TBI.
A large nationwide cohort study found no evidence that preinjury antidepressant use increases short-term mortality, need for emergency brain surgery, or length of hospitalization following TBI.
A large nationwide cohort study...
02/03/2026
Psych Congress Network
a mother and daughter sit at a table
News
Fremanezumab Reduces Migraine Days in Pediatric Episodic Migraine
01/30/2026
Maria Mantas
In a recent randomized, placebo-controlled trial, researchers found that fremanezumab significantly reduced monthly migraine days compared with placebo in children and adolescents with episodic migraine. 
In a recent randomized, placebo-controlled trial, researchers found that fremanezumab significantly reduced monthly migraine days compared with placebo in children and adolescents with episodic migraine. 
In a recent randomized,...
01/30/2026
Neurology

Migraine CME Series

News

broken DNA strand
News
Gene Therapy May Offer an Effective Alternative to Cochlear Implantation in Patients With Congenital Deafness
07/25/2025
Maria Mantas
Patients with congenital deafness who received OTOF gene therapy saw stable hearing recovery and faster improvements in auditory and speech performance than those who had received cochlear implantation.
Patients with congenital deafness who received OTOF gene therapy saw stable hearing recovery and faster improvements in auditory and speech performance than those who had received cochlear implantation.
Patients with congenital...
07/25/2025
Neurology
Doctors examine brain scans
News
GLP-1 RAs May Offer Novel Approach for Idiopathic Intracranial Hypertension Management
07/21/2025
Jolynn Tumolo
Patients with idiopathic intracranial hypertension (IIH) treated with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) had lower medication use, fewer symptoms, and a reduced need for procedural interventions.
Patients with idiopathic intracranial hypertension (IIH) treated with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) had lower medication use, fewer symptoms, and a reduced need for procedural interventions.
Patients with idiopathic...
07/21/2025
Neurology
An orange prescription container with generic pills spilling out in front of it
News
Association Found Between Psychiatric Medication Use and Risk of ALS
06/18/2025
Brionna Mendoza
A case-control study has identified a potential link between use of certain psychiatric medications and the risk and progression of amyotrophic lateral sclerosis (ALS). Findings were published in JAMA Network Open.
A case-control study has identified a potential link between use of certain psychiatric medications and the risk and progression of amyotrophic lateral sclerosis (ALS). Findings were published in JAMA Network Open.
A case-control study has...
06/18/2025
Neurology
diagnosing brain injury
News
Intensive Blood Pressure Reduction After ICH Not Linked to Ischemic Lesions
04/28/2025
Meagan Thistle
Intensive systolic blood pressure (SBP) lowering after intracerebral hemorrhage (ICH) does not increase the risk of ischemic brain injury, according to a new randomized clinical trial.
Intensive systolic blood pressure (SBP) lowering after intracerebral hemorrhage (ICH) does not increase the risk of ischemic brain injury, according to a new randomized clinical trial.
Intensive systolic blood...
04/28/2025
Neurology
A new mom sits on the couch holding her infant, and her forehead
News
Gestational Hypertension, Preeclampsia, and Eclampsia Associated With Greater Incidence of Future Neurological Disorders
02/13/2025
Brionna Mendoza
A recent Swedish cohort study of primiparous women found that those who experienced gestational hypertension, preeclampsia, and eclampsia were at increased risk for new-onset neurological disorders months or years after giving birth.
A recent Swedish cohort study of primiparous women found that those who experienced gestational hypertension, preeclampsia, and eclampsia were at increased risk for new-onset neurological disorders months or years after giving birth.
A recent Swedish cohort study of...
02/13/2025
Neurology
A person holds a cannabis joint in their hands
News
Cannabis Use Linked With Diminished Brain Activation in Young Adults
02/11/2025
Jolynn Tumolo
A lifetime history of heavy cannabis use in young adults was associated with lower brain activation during a working memory task, according to a study in JAMA Network Open
A lifetime history of heavy cannabis use in young adults was associated with lower brain activation during a working memory task, according to a study in JAMA Network Open
A lifetime history of heavy...
02/11/2025
Neurology
Intensive Blood Pressure Control Lowers Cognitive Impairment Risk Years Later
News
Intensive Blood Pressure Control Lowers Cognitive Impairment Risk Years Later
02/05/2025
Jolynn Tumolo
Just over 3 years of intensive treatment to reduce systolic blood pressure in adults with hypertension and high cardiovascular risk resulted in a lower rate of cognitive impairment 7 years later, according to a study published in Neurology.
Just over 3 years of intensive treatment to reduce systolic blood pressure in adults with hypertension and high cardiovascular risk resulted in a lower rate of cognitive impairment 7 years later, according to a study published in Neurology.
Just over 3 years of intensive...
02/05/2025
Neurology
Researchers Report Best Times for Biomarker Assessment After NMOSD Attacks
News
Researchers Report Best Times for Biomarker Assessment After NMOSD Attacks
02/03/2025
Jolynn Tumolo
The optimal times to assess sGFAP and sNfL when evaluating attacks in patients with neuromyelitis optica spectrum disorder (NMOSD) were within 1 week for sGFAP and 1 to 8 weeks for sNfL, according to study results published in JAMA Neurology.
The optimal times to assess sGFAP and sNfL when evaluating attacks in patients with neuromyelitis optica spectrum disorder (NMOSD) were within 1 week for sGFAP and 1 to 8 weeks for sNfL, according to study results published in JAMA Neurology.
The optimal times to assess...
02/03/2025
Neurology
Brain health
News
Mood Changes May Be a Prodromal Symptom in Sporadic Creutzfeldt-Jakob Disease
01/09/2025
Brionna Mendoza
Mood changes may precede symptom onset in sporadic Creutzfeldt-Jakob disease (sCJD) as early as 3 years, according to the findings from a retrospective case-control study published in JAMA Neurology.
Mood changes may precede symptom onset in sporadic Creutzfeldt-Jakob disease (sCJD) as early as 3 years, according to the findings from a retrospective case-control study published in JAMA Neurology.
Mood changes may precede symptom...
01/09/2025
Neurology
Investigational Drug Improves Motor Function in Patients With SMA
News
Investigational Drug Improves Motor Function in Patients With SMA
10/16/2024
Jolynn Tumolo
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational...
10/16/2024
Neurology
a woman holds another person's hand for support
News
Suicidality at Epilepsy Diagnosis Predicts Future Drug Resistance Risk
03/16/2026
Maria Mantas
A prospective cohort study found that suicidality at the time of focal epilepsy diagnosis was linked to a more than twofold increased risk of future antiseizure medication (ASM) treatment resistance.
A prospective cohort study found that suicidality at the time of focal epilepsy diagnosis was linked to a more than twofold increased risk of future antiseizure medication (ASM) treatment resistance.
A prospective cohort study found...
03/16/2026
Neurology
A woman lies on the couch holding an ice pack to her head
News
Migraine Nearly Doubles Depression and Anxiety Risk in Cohort Study
03/10/2026
Brionna Mendoza
Patients with migraine are at 2 times the risk for depression or anxiety compared to those without migraine, according to a large nationwide Swedish cohort study published in The Journal of Headache and Pain.
Patients with migraine are at 2 times the risk for depression or anxiety compared to those without migraine, according to a large nationwide Swedish cohort study published in The Journal of Headache and Pain.
Patients with migraine are at 2...
03/10/2026
Psych Congress Network
A nurse and a doctor review information on a computer in a lab clinical study research trial
News
Fenebrutinib for Multiple Sclerosis Returns Significant Phase III Results
03/04/2026
Brionna Mendoza
The pivotal Phase III FENhance 1 trial of fenebrutinib met its primary endpoint in relapsing multiple sclerosis (RMS), demonstrating statistically significant and clinically meaningful reductions in relapse activity.
The pivotal Phase III FENhance 1 trial of fenebrutinib met its primary endpoint in relapsing multiple sclerosis (RMS), demonstrating statistically significant and clinically meaningful reductions in relapse activity.
The pivotal Phase III FENhance 1...
03/04/2026
Neurology
a bowl of fruits and vegetables indicates brain health
News
DASH Diet Linked to Lower Subjective Cognitive Decline Risk
03/02/2026
Maria Mantas
In a prospective cohort of 159,347 US adults, higher adherence to 6 healthy dietary patterns was associated with lower risk of subjective cognitive decline (SCD).
In a prospective cohort of 159,347 US adults, higher adherence to 6 healthy dietary patterns was associated with lower risk of subjective cognitive decline (SCD).
In a prospective cohort of...
03/02/2026
Neurology
a colorful illustration of the brain
News
Five-Year Ublituximab Efficacy Sustained in Relapsing MS Trial
02/23/2026
Maria Mantas
Ublituximab provided sustained reductions in disease activity and disability progression over 5 years in adults with relapsing multiple sclerosis (RMS), according to open-label extension study findings.
Ublituximab provided sustained reductions in disease activity and disability progression over 5 years in adults with relapsing multiple sclerosis (RMS), according to open-label extension study findings.
Ublituximab provided sustained...
02/23/2026
Neurology
a row of pill bottles on a shelf
News
Cenobamate Shows Superior Effectiveness in Drug-Resistant Focal Epilepsy
02/17/2026
Maria Mantas
A large, pooled analysis found that cenobamate outperformed brivaracetam, lacosamide, and perampanel as adjunctive therapy in adults with drug-resistant focal epilepsy.
A large, pooled analysis found that cenobamate outperformed brivaracetam, lacosamide, and perampanel as adjunctive therapy in adults with drug-resistant focal epilepsy.
A large, pooled analysis found...
02/17/2026
Neurology
Two doctors review research data on a computer in a lab
News
Intravenous Tenecteplase Improves Functional Outcomes in Extended-Window Non-LVO Stroke
02/12/2026
Brionna Mendoza
The OPTION randomized clinical trial investigated whether intravenous tenecteplase administered in an extended time window after ischemic stroke onset benefits patients with non-large vessel occlusion (non-LVO) and evidence of salvageable...
The OPTION randomized clinical trial investigated whether intravenous tenecteplase administered in an extended time window after ischemic stroke onset benefits patients with non-large vessel occlusion (non-LVO) and evidence of salvageable...
The OPTION randomized clinical...
02/12/2026
Neurology
a doctor reviews brain scans
News
Phase 2 Odatroltide Trials Show Promise for Acute Ischemic Stroke Patients
02/09/2026
Maria Mantas
Data from 2 phase 2 trials suggest that LT3001 (odatroltide), a novel dual-mechanism stroke therapy, may offer functional improvement in patients with acute ischemic stroke who cannot receive standard reperfusion treatments.
Data from 2 phase 2 trials suggest that LT3001 (odatroltide), a novel dual-mechanism stroke therapy, may offer functional improvement in patients with acute ischemic stroke who cannot receive standard reperfusion treatments.
Data from 2 phase 2 trials...
02/09/2026
Neurology
An orange prescription container with generic pills spilling out in front of it
News
Antidepressant Use Not Linked to Worse Traumatic Brain Injury Outcomes
02/03/2026
Brionna Mendoza
A large nationwide cohort study found no evidence that preinjury antidepressant use increases short-term mortality, need for emergency brain surgery, or length of hospitalization following TBI.
A large nationwide cohort study found no evidence that preinjury antidepressant use increases short-term mortality, need for emergency brain surgery, or length of hospitalization following TBI.
A large nationwide cohort study...
02/03/2026
Psych Congress Network
a mother and daughter sit at a table
News
Fremanezumab Reduces Migraine Days in Pediatric Episodic Migraine
01/30/2026
Maria Mantas
In a recent randomized, placebo-controlled trial, researchers found that fremanezumab significantly reduced monthly migraine days compared with placebo in children and adolescents with episodic migraine. 
In a recent randomized, placebo-controlled trial, researchers found that fremanezumab significantly reduced monthly migraine days compared with placebo in children and adolescents with episodic migraine. 
In a recent randomized,...
01/30/2026
Neurology

Alzheimer's Disease CME Series

Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/17/2020
Neurology

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use